Vattenfall IDNO has energised a new high-voltage grid connection for a pioneering immunology research facility operated by RoukenBio, near Glasgow.
The new 11kV point of connection will supply power to RoukenBio’s recently expanded 24,000-square-foot research site, which delivers a 55% increase in laboratory and office space, forming part of the second phase of the organisation’s growth.
To enable the connection, Vattenfall IDNO partnered with an Independent Connection Provider (ICP) to design and deliver a new substation. This includes transformers, switchgear and cables providing a 1200kVA supply.
Vattenfall IDNO now owns and operates the electrical infrastructure delivering power to the site with phase three of RoukenBio’s development is scheduled to begin in 2025.
The facility is expected to have a significant impact on RoukenBio’s ability to support global clients. The additional space and investment in state-of-the-art instrumentation will enhance testing capabilities and allow more efficient development of new therapeutics.
Stewart Dawson, Managing Director at Vattenfall IDNO, said:
“As an IDNO, we are keen to support electrification projects that contribute to the UK’s net zero ambitions.
“This has been a fantastic collaboration, and we look forward to supporting more innovative projects like this in the future.”
Andy Upsall, CEO of RoukenBio, said:
“This new facility is a game-changer for our research capabilities.
“The increased space and advanced equipment will significantly enhance our capacity, enabling us to support our clients in the development of much-needed new therapeutics for immune-regulated diseases. We are grateful for the support from Vattenfall IDNO in making this possible.”
Image courtesy of Vattenfall IDNO/RoukenBio
